34170117|t|Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide.
34170117|a|Alzheimer's disease is the most common neurodegenerative disorder characterized by the pathological aggregation of amyloid-beta (Abeta) peptide. A potential therapeutic intervention in Alzheimer's disease is to enhance Abeta degradation by increasing the activity of Abeta-degrading enzymes, including neprilysin. The somatostatin (SST) peptide has been identified as an activator of neprilysin. Recently, we demonstrated the ability of a brain-penetrating SST peptide (SST-scFv8D3) to increase neprilysin activity and membrane-bound Abeta42 degradation in the hippocampus of mice overexpressing the Abeta-precursor protein with the Swedish mutation (APPswe). Using LC-MS, we further evaluated the anti-Alzheimer's disease effects of SST-scFv8D3. Following a triple intravenous injection of SST-scFv8D3, the LC-MS analysis of the brain proteome revealed that the majority of downregulated proteins consisted of mitochondrial proteins regulating fatty acid oxidation, which are otherwise upregulated in APPswe mice compared to wild-type mice. Moreover, treatment with SST-scFv8D3 significantly increased hippocampal levels of synaptic proteins regulating cell membrane trafficking and neuronal development. Finally, hippocampal concentrations of growth-regulated alpha (KC/GRO) chemokine and degradation of neuropeptide-Y were elevated after SST-scFv8D3 treatment. In summary, our results demonstrate a multifaceted effect profile in regulating mitochondrial function and neurogenesis following treatment with SST-scFv8D3, further suggesting the development of Alzheimer's disease therapies based on SST peptides.
34170117	59	64	Mouse	Species	10090
34170117	74	93	Alzheimer's Disease	Disease	MESH:D000544
34170117	137	149	Somatostatin	Gene	20604
34170117	159	178	Alzheimer's disease	Disease	MESH:D000544
34170117	198	224	neurodegenerative disorder	Disease	MESH:D019636
34170117	288	293	Abeta	Gene	11820
34170117	344	363	Alzheimer's disease	Disease	MESH:D000544
34170117	378	383	Abeta	Gene	11820
34170117	426	431	Abeta	Gene	11820
34170117	461	471	neprilysin	Gene	17380
34170117	477	489	somatostatin	Gene	20604
34170117	491	494	SST	Gene	20604
34170117	543	553	neprilysin	Gene	17380
34170117	629	632	SST	Gene	20604
34170117	633	640	scFv8D3	Chemical	-
34170117	654	664	neprilysin	Gene	17380
34170117	735	739	mice	Species	10090
34170117	862	881	Alzheimer's disease	Disease	MESH:D000544
34170117	893	896	SST	Gene	20604
34170117	897	904	scFv8D3	Chemical	-
34170117	950	953	SST	Gene	20604
34170117	954	961	scFv8D3	Chemical	-
34170117	1104	1114	fatty acid	Chemical	MESH:D005227
34170117	1168	1172	mice	Species	10090
34170117	1195	1199	mice	Species	10090
34170117	1226	1229	SST	Gene	20604
34170117	1230	1237	scFv8D3	Chemical	-
34170117	1431	1434	GRO	Gene	14825
34170117	1465	1479	neuropeptide-Y	Gene	109648
34170117	1500	1503	SST	Gene	20604
34170117	1504	1511	scFv8D3	Chemical	-
34170117	1668	1671	SST	Gene	20604
34170117	1672	1679	scFv8D3	Chemical	-
34170117	1719	1738	Alzheimer's disease	Disease	MESH:D000544
34170117	1758	1761	SST	Gene	20604
34170117	Negative_Correlation	MESH:D000544	20604
34170117	Positive_Correlation	17380	20604
34170117	Association	MESH:D000544	17380
34170117	Positive_Correlation	14825	20604
34170117	Association	11820	17380
34170117	Negative_Correlation	109648	20604
34170117	Negative_Correlation	MESH:D000544	11820

